Fabagal^®

International nonproprietary name

Agalsidase beta

Description

A drug for therapy of the orphan Fabry disease.

Application

For long-term enzyme replacement therapy of patients with confirmed diagnosis of Fabry disease (a rare genetically determined disease, causing kidney problems, neuropathic limb pain, congestive heart failure and stroke).